1343 / 1708
Conclusion
•
Proton therapy offers a CHANCE
for improved sparing of
normal tissue (or dose intensification)
•
Advantage greater
for large target volumes, in high doses
and in very young
•
Increasing role in children
worldwide
•
Experiences in on-CNS tumours:
mainly Sarcomas
, …
•
Increasingly
neuroblastomas, nephroblastomas,
lymphomas
•
To be implemented into
multidisciplinary framework/trials
(SIOP, GPOH…)
•
Increasing capacity in Europe and elsewhere
•
At WPE/Essen particular focus on children
•
Data
on PT (as on any other technique!) to be collected and
evaluated (toxicity/TU but also QoL & neuropsych.)